Progentix Orthobiology B.V. closes Series A financing round
Advertisement
Progentix Orthobiology B.V. announced the closure of its Series A financing Round. The round was led by BioGeneration Ventures. Progentix Orthobiology B.V. was established in 2007 and develops a unique suite of osteoinductive material products for clinical application in bone regenerative surgery.
Progentix bone graft material is based on surface structured ceramic biomaterial scaffolds that have the ability to attract growth factors and stems cells after implantation, which results in the induction of bone growth. According to the company, these materials are not only superior to currently available synthetic ceramic bone grafts, but based on their bone healing and regeneration potential also directly compete with the gold standard of autologous bone, and the growth factors that are being used today and those under development. The Series A financing round will support further technology validation and the generation of clinical proof of principle.
Dr. Joost de Bruijn, CEO of Progentix Orthobiology said: "We are extremely pleased with the support of BioGeneration Ventures. This financing round will allow us to continue building value and lay the groundwork for the launch of our first products in the near future".
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Progenika Biopharma SA creates a subsidiary in the UK
ISO 9001:2008 certificate for Altmann Analytik by TÜV Süd
Health_insurance
GenScript to Synthesize Yeast Genome with Johns Hopkins Scientists
American_College_of_Pediatricians
BioASP portal provides Dutch researchers access to Rosetta Resolver software in National Genomics Initiative

Scallop Eyes as Inspiration for New Microscope Objectives - New lens can be produced much more cheaply and offers equivalent or even better image quality than conventional lenses
